Drug comparisons
Insulin Aspart Human vs Troglitazone
Compare Insulin Aspart (fast-acting injectable insulin) and Troglitazone (oral TZD withdrawn for liver risks). Insulin Aspart remains a standard treatment for diabetes.
No comparison dimensions are available for this page.
Clinical context
Patients with type 2 diabetes who are considering oral medications versus injectable options may compare Insulin Aspart to the discontinued Troglitazone.
Bottom line
Insulin Aspart is a viable and commonly prescribed treatment for diabetes, whereas Troglitazone has been removed from the market due to safety concerns.
All medication comparisons